Medpage Today on MSN
Popular Oral Drug for Diabetes May Hold 'Intriguing' Side Benefit
In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback